ConductScience.org, home

Paper2146239

Kinetic analysis of 5-fluorouracil action against various cancer cells.

Inaba M and 2 others. Jpn J Cancer Res, 1990. Cited by 40 papers, by iCite.

Cite this record

ConductScience Library. Kinetic analysis of 5-fluorouracil action against various cancer cells. Papers, record 2146239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2146239

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Kinetic analysis of 5-fluorouracil action against various cancer cells.
PubMed
Journal
Jpn J Cancer Res
PubMed
Year
1990
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
40
iCite
Relative citation ratio, by iCite
1.49
iCite
Revised in PubMed
2019-05-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Inaba MM
2Mitsuhashi JJ
3Ozawa SS

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cell CycleMajor topic
FluorouracilMajor topic
Animals
Antineoplastic Agents
Colonic Neoplasms
Dose-Response Relationship, Drug
Floxuridine
Humans
Kidney Neoplasms
Leukemia P388
Mice
RNA, Ribosomal
S Phase
Time Factors
Uridine

Source PubMed

Download CSV of topics

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13129204Cell killing action of cell cycle phase-non-specific antitumor agents is dependent on concentration--time product.Cancer Chemother Pharmacol1988https://conductscience.org/library/papers/3129204PubMed
23732354Binding of 5-fluorodeoxyuridylate to thymidylate synthase in human colon adenocarcinoma xenografts.Eur J Cancer Clin Oncol1986https://conductscience.org/library/papers/3732354PubMed
36766799Treatment of cultured human colon carcinoma cells with fluorinated pyrimidines.Cancer1980https://conductscience.org/library/papers/6766799PubMed
43008760Relationship between 5-fluoro-2'-deoxyuridylate, 2'-deoxyuridylate, and thymidylate synthase activity subsequent to 5-fluorouracil administration, in xenografts of human colon adenocarcinomas.Biochem Pharmacol1986https://conductscience.org/library/papers/3008760PubMed
52578606Cytotoxicity and the inhibition of ribosomal RNA processing in human colon carcinoma cells.Mol Pharmacol1985https://conductscience.org/library/papers/2578606PubMed
64258018Cell cycle phase specificity of antitumor agents.Cancer Res1972https://conductscience.org/library/papers/4258018PubMed
72736524Kinetic analysis of cell killing effect induced by cytosine arabinoside and cisplatin in relation to cell cycle phase specificity in human colon cancer and Chinese hamster cells.Cancer Res1989https://conductscience.org/library/papers/2736524PubMed
86688119Relationship of cellular folate cofactor pools to the activity of 5-fluorouracil.Mol Pharmacol1983https://conductscience.org/library/papers/6688119PubMed
96444543On the mechanism of cytotoxicity of fluorinated pyrimidines in four human colon adenocarcinoma xenografts maintained in immune-deprived mice.Cancer1980https://conductscience.org/library/papers/6444543PubMed
103698176The inhibitory effects of 5-fluorouracil on the metabolism of preribosomal and ribosomal RNA in L-1210 cells in vitro.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3698176PubMed
112971656Mechanism of the cytotoxic synergism of fluoropyrimidines and folinic acid in mouse leukemic cells.J Biol Chem1988https://conductscience.org/library/papers/2971656PubMed
126162543Assessment of growth-limiting events caused by 5-fluorouracil in mouse cells and in human cells.Cancer Res1980https://conductscience.org/library/papers/6162543PubMed
137448754Biochemical determinants of responsiveness to 5-fluorouracil and its derivatives in xenografts of human colorectal adenocarcinomas in mice.Cancer Res1981https://conductscience.org/library/papers/7448754PubMed
146973389Effect of excess folates and deoxyinosine on the activity and site of action of 5-fluorouracil.Cancer Res1981https://conductscience.org/library/papers/6973389PubMed
157099147Association of cell lethality with incorporation of 5-fluorouracil and 5-fluorouridine into nuclear RNA in human colon carcinoma cells in culture.Mol Pharmacol1982https://conductscience.org/library/papers/7099147PubMed
164348213Inhibition of ribosomal ribonucleic acid maturation in Novikoff hepatoma cells by 5-fluorouracil and 5-fluorouridine.J Biol Chem1973https://conductscience.org/library/papers/4348213PubMed
176173112In vivo kinetics of thymidylate synthetase inhibition of 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas.Cancer Res1982https://conductscience.org/library/papers/6173112PubMed
186565175Lethality associated with incorporation of 5-fluorouracil into preribosomal RNA.Mol Pharmacol1984https://conductscience.org/library/papers/6565175PubMed
196744325Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracil.Cancer Res1984https://conductscience.org/library/papers/6744325PubMed
20498116Effect of 5-fluorouracil on RNA metabolism in Novikoff hepatoma cells.Cancer Res1979https://conductscience.org/library/papers/498116PubMed

See all 28 referencesDownload CSV of references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.

PMIDTitleJournalYearIn PapersSource
27478804Carcinoembryonic Antigen Expression and Resistance to Radiation and 5-Fluorouracil-Induced Apoptosis and Autophagy.Int J Mol Cell Med2016https://conductscience.org/library/papers/27478804PubMed
14586206In vivo antitumor activity of a novel sulfonamide, HMN-214, against human tumor xenografts in mice and the spectrum of cytotoxicity of its active metabolite, HMN-176.Invest New Drugs2003https://conductscience.org/library/papers/14586206PubMed
12630975Population pharmacokinetics and concentration-effect relationships of capecitabine metabolites in colorectal cancer patients.Br J Clin Pharmacol2003https://conductscience.org/library/papers/12630975PubMed
10804291Schedule-dependent interactions between raltitrexed and cisplatin in human carcinoma cell lines in vitro.Jpn J Cancer Res2000https://conductscience.org/library/papers/10804291PubMed
10359051Circumvention of 5-fluorouracil resistance in human stomach cancer cells by uracil phosphoribosyltransferase gene transduction.Jpn J Cancer Res1999https://conductscience.org/library/papers/10359051PubMed
9811349Thymidine phosphorylase activity and prodrug effects in a three-dimensional model of angiogenesis: implications for the treatment of ovarian cancer.Am J Pathol1998https://conductscience.org/library/papers/9811349PubMed
97921405-Fluorouracil induces apoptosis in human colon cancer cell lines with modulation of Bcl-2 family proteins.Br J Cancer1998https://conductscience.org/library/papers/9792140PubMed
9600127Increased sensitivity to long-term 5-fluorouracil exposure of human colon cancer HT-29 cells resistant to short-term exposure.Jpn J Cancer Res1998https://conductscience.org/library/papers/9600127PubMed
8912534Pharmacological effects of 5-fluorouracil microspheres on peritoneal carcinomatosis in animals.Br J Cancer1996https://conductscience.org/library/papers/8912534PubMed
8609072Reduced activity of anabolizing enzymes in 5-fluorouracil-resistant human stomach cancer cells.Jpn J Cancer Res1996https://conductscience.org/library/papers/8609072PubMed
8400672A pharmacodynamic and pharmacokinetic study of fluoropyrimidines in a nude mouse system and in postoperative patients with gastric cancer.Surg Today1993https://conductscience.org/library/papers/8400672PubMed
8144400Different modes of cell-killing action between DNA topoisomerase I and II inhibitors revealed by kinetic analysis.Jpn J Cancer Res1994https://conductscience.org/library/papers/8144400PubMed
1618703Kinetic analysis of combination effect of navelbine (KW-2307) with cisplatin against human lung adenocarcinoma PC-12 cells in culture.Jpn J Cancer Res1992https://conductscience.org/library/papers/1618703PubMed
1506275Cell-killing activity and kinetic analysis of a novel antitumor compound NC-190, a benzo[a]phenazine derivative.Jpn J Cancer Res1992https://conductscience.org/library/papers/1506275PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2146239

GET https://conductscience.org/api/papers/v1/2146239/references?page=2